|
Pharmacological Group: Antivirals, Active Principle: Aciclovir Sodico, Pharmaceutical Form: Injectable Po Liophilo, Concentration / Dosage: 250, Unit: Mg, Volume: Not Applicable, Introduction: Not Applicable, Pharmacological Group: Antiparasitarians, Active Principle: Albendazol, Pharmaceutical Form, Concentration, Concentration Dosage: 400, Presentation: Not Applicable, Pharmacological Group: Modifying Disease Drugs On Rheumatoid And Adjuvant Disorders, Active Principle: Sodico Alendronate, Concentration/Dosage: 70, Volume: N/A, N/A, N/A, Pharmacological Group: Antigotosus, Active Principle: 100, Group Pharmacological: Expectorants, Fluidifying And Nasal Decongestants, Active Principle: Ambroxol Hydrochloride, Pharmaceutical Form: Syrup, Concentration/Dosage: 30Mg/5Ml, Unit: Mg/Ml, Volume: 120Ml, Presentation: Vial, 20/03/2025, Pharmacologic Group: Antihirtensive, Active Principle: Atenolol, Concentration / Dosage: 50, Pharmacological Group: Vitamins And Mineral Substances, Active Principle: Calcium Carbonate (Equivalent To 500 Mg Of Calcium), Concentration / Dosage: 1250, Pharmacological Group: Antialergic, Active Principle: Dexclorpheniramine Maleate, Pharmaceutical Form: Oral Solution, Concentration / Dosage 2Mg / 5Ml, Active Principle: Dexclorpheniramine Maleate, Concentration / Dosage: 2, Pharmacological Group: Analgesic And Antipiretic, Active Principle: Sodica Dipyrone, Pharmaceutical Form: Oral Solution - Drops, Concentration / Dosage: 500, Volume: 10Ml
|
